McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The latest trading session saw McKesson (MCK) ending at $602.95, denoting a -0.24% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.92% for the ...

Geneos Wealth Management Inc. increased its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 5.6% in the 4th ...

On January 21, 2025, the Supreme Court heard oral arguments in McLaughlin Chiropractic Associates, Inc. v. McKesson Corporation, et al., a case ...

The West Virginia Supreme Court heard oral arguments Tuesday, Jan. 28, 2025, from attorneys for the city and county, as well ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Cabell County and Huntington's eight-year legal fight with pain pill distributors had a critical round before the West Virginia Supreme Court.

A lawsuit filed by the Cabell County Commission and the City of Huntington against some of the country’s biggest drug ...

ScribeAI, an innovative healthcare technology company, today announced its official launch out of stealth mode. By leveraging artificial intelligence (AI) to transform clinician-patient interactions ...

KnowBe4, the world-renowned cybersecurity platform that comprehensively addresses human risk management, today announced its new Threat Labs to mitigate human-targeted cybersecurity attacks. This ...

Introduction Cerumen is a natural substance produced in the ear canal to protect the ears from dust, debris, and microorganisms. It also helps ...

Wells Fargo analyst Stephen Baxter raised the firm’s price target on Cencora (COR) to $251 from $237 and keeps an Equal Weight rating on the ...